Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kunst

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 7, 2015
Differential immuno-reactivity to genomic DNA, RNA and mitochondrial DNA is associated with auto-immunityVilena V Ivanova, Svetlana F Khaiboullina, Ekaterina E Cherenkova, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 29, 2022
[Current and future therapeutic options for COVID-19]Marloes Dankers, H Marjorie J M G Nelissen-Vrancken, Marjolein Y Berger, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 27, 2007
Initial bronchoscopic treatment for patients with intraluminal bronchial carcinoidsHes A P Brokx, Elle K Risse, Marinus A Paul, et al.
Terapevticheskii Arkhiv|October 26, 2022
[Multiple myeloma: response to treatment and survival of patients according to the interim analysis of the Russian observational, retrospective-prospective, multicenter cohort study (MULTISPECT)]V V Ptushkin, M A Kunst, T A Mitina, et al.
International Journal of Cancer|January 25, 2024
Continuity of care for patients with de novo metastatic cancer during the COVID-19 pandemic: A population-based observational studyEllis Slotman, Feike Weijzen, Heidi P Fransen, et al.
Journal for Immunotherapy of Cancer|June 22, 2026
Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trialEzgi B Ulas, Nora D Purcell, Ilias Houda, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 26, 2023
Clinical Outcomes in Patients With COVID-19 and Hematologic DiseaseOlga A Aleshina, Kristina Zakurdaeva, Anastasia N Vasileva, et al.
The Lancet. Respiratory Medicine|June 20, 2021
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trialJurjan Aman, Erik Duijvelaar, Liza Botros, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|January 7, 2015
Differential immuno-reactivity to genomic DNA, RNA and mitochondrial DNA is associated with auto-immunityVilena V Ivanova, Svetlana F Khaiboullina, Ekaterina E Cherenkova, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 29, 2022
[Current and future therapeutic options for COVID-19]Marloes Dankers, H Marjorie J M G Nelissen-Vrancken, Marjolein Y Berger, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 27, 2007
Initial bronchoscopic treatment for patients with intraluminal bronchial carcinoidsHes A P Brokx, Elle K Risse, Marinus A Paul, et al.
Terapevticheskii Arkhiv|October 26, 2022
[Multiple myeloma: response to treatment and survival of patients according to the interim analysis of the Russian observational, retrospective-prospective, multicenter cohort study (MULTISPECT)]V V Ptushkin, M A Kunst, T A Mitina, et al.
International Journal of Cancer|January 25, 2024
Continuity of care for patients with de novo metastatic cancer during the COVID-19 pandemic: A population-based observational studyEllis Slotman, Feike Weijzen, Heidi P Fransen, et al.
Journal for Immunotherapy of Cancer|June 22, 2026
Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trialEzgi B Ulas, Nora D Purcell, Ilias Houda, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 26, 2023
Clinical Outcomes in Patients With COVID-19 and Hematologic DiseaseOlga A Aleshina, Kristina Zakurdaeva, Anastasia N Vasileva, et al.
The Lancet. Respiratory Medicine|June 20, 2021
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trialJurjan Aman, Erik Duijvelaar, Liza Botros, et al.
Pageof 5